TY - JOUR
T1 - A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE project
AU - Balcar, Lorenz
AU - Schwarz, Michael
AU - Dorn, Livia
AU - Jachs, Mathias
AU - Hartl, Lukas
AU - Weseslindtner, Lukas
AU - Pfisterer, Nikolaus
AU - Hennlich, Barbara
AU - Stückler, Annika
AU - Strassl, Robert
AU - Voill-Glaninger, Astrid
AU - Hübl, Wolfgang
AU - Willheim, Martin
AU - Köhrer, Karin
AU - Jansen-Skoupy, Sonja
AU - Tomez, Sabine
AU - Krugluger, Walter
AU - Madl, Christian
AU - Burghart, Lukas
AU - Antonitsch, Lukas
AU - Weidinger, Gerhard
AU - Riedl, Florian
AU - Laferl, Hermann
AU - Hind, Julian
AU - Wenisch, Christoph
AU - Sebesta, Christian
AU - Wachter-Welzl, Julia
AU - Watzl, Paul
AU - Neuhauser, Magdalena
AU - Chromy, David
AU - Mandorfer, Mattias
AU - Schmid, Daniela
AU - Gschwantler, Michael
AU - Reiberger, Thomas
AU - Maieron, Andreas
AU - Bauer, David J M
AU - Schwarz, Caroline
N1 - Publisher Copyright:
© 2024 The Author(s). Liver International published by John Wiley & Sons Ltd.
PY - 2024/12
Y1 - 2024/12
N2 - BACKGROUND AND AIMS: Identification of people living with hepatitis C virus (HCV) via readily available laboratory records could be a key strategy for macro-elimination, aligning with the WHO elimination goal. Therefore, the ELIMINATE(ELIMINation of HCV in AusTria East) project aimed to systematically re-link people with a 'last-positive' HCV-RNA PCR record to care.METHODS: In 10 major liver centres in Eastern Austria, a systematic readout of 'last-positive' HCV-RNA PCR test records obtained between 2008 and 2020 were conducted and linked to available patient contact data. Between 2020 and 2023, individuals were contacted first by phone, then by letter, to inform them about the availability of effective direct-acting antiviral (DAA) treatment and invite them for pre-treatment evaluation.RESULTS: The overall cohort of last-positive HCV+ individuals included 5695 subjects (62.5% males, mean age 57.3 ± 17.3 years); of note, 1931 (34%) of them had died and 759 (13%) individuals had no valid contact information. Of the remaining 3005 individuals, 1171 (40.0%) had already achieved sustained virological response (SVR) at the time of re-call. We successfully reached 617 (20.5%), of whom 417 (67.6%) attended their pre-treatment visit, and 397 (64.3%) commenced DAA-therapy. HCV cure has been confirmed in 326 individuals, corresponding to an SVR rate of 82.1%.CONCLUSION: The ELIMINATE project identified 5695 people living with HCV who were 'lost to care' despite documented HCV viraemia. While invalid contact data were an evident barrier to HCV elimination, premature deaths among the cohort underscored the severity of untreated HCV. The implementation of a systematic HCV-RNA PCR recorded-based re-call workflow represents an effective strategy supporting the WHO goal of HCV elimination.
AB - BACKGROUND AND AIMS: Identification of people living with hepatitis C virus (HCV) via readily available laboratory records could be a key strategy for macro-elimination, aligning with the WHO elimination goal. Therefore, the ELIMINATE(ELIMINation of HCV in AusTria East) project aimed to systematically re-link people with a 'last-positive' HCV-RNA PCR record to care.METHODS: In 10 major liver centres in Eastern Austria, a systematic readout of 'last-positive' HCV-RNA PCR test records obtained between 2008 and 2020 were conducted and linked to available patient contact data. Between 2020 and 2023, individuals were contacted first by phone, then by letter, to inform them about the availability of effective direct-acting antiviral (DAA) treatment and invite them for pre-treatment evaluation.RESULTS: The overall cohort of last-positive HCV+ individuals included 5695 subjects (62.5% males, mean age 57.3 ± 17.3 years); of note, 1931 (34%) of them had died and 759 (13%) individuals had no valid contact information. Of the remaining 3005 individuals, 1171 (40.0%) had already achieved sustained virological response (SVR) at the time of re-call. We successfully reached 617 (20.5%), of whom 417 (67.6%) attended their pre-treatment visit, and 397 (64.3%) commenced DAA-therapy. HCV cure has been confirmed in 326 individuals, corresponding to an SVR rate of 82.1%.CONCLUSION: The ELIMINATE project identified 5695 people living with HCV who were 'lost to care' despite documented HCV viraemia. While invalid contact data were an evident barrier to HCV elimination, premature deaths among the cohort underscored the severity of untreated HCV. The implementation of a systematic HCV-RNA PCR recorded-based re-call workflow represents an effective strategy supporting the WHO goal of HCV elimination.
KW - Disease Eradication/methods
KW - Hepacivirus/genetics
KW - Humans
KW - Middle Aged
KW - Male
KW - Hepatitis C/drug therapy
KW - Polymerase Chain Reaction/methods
KW - RNA, Viral
KW - Antiviral Agents/therapeutic use
KW - Austria/epidemiology
KW - Female
KW - Adult
KW - Hepatitis C, Chronic/drug therapy
KW - Aged
KW - Sustained Virologic Response
UR - http://www.scopus.com/inward/record.url?scp=85205464195&partnerID=8YFLogxK
U2 - 10.1111/liv.16076
DO - 10.1111/liv.16076
M3 - Journal article
C2 - 39351692
SN - 1478-3223
VL - 44
SP - 3151
EP - 3163
JO - Liver International
JF - Liver International
IS - 12
ER -